Although it's not always easy to determine if an individual can make decisions, a judge understands the obvious that a ...

ALZpath’s pTau217 antibody was released in 2023 and continues to be a key focus in Alzheimer’s disease research and ...

Researchers say the repurposed drugs could accelerate a long-stalled path toward meaningful Alzheimer’s treatment. (Scripps ...

Microglia, a type of brain immune cell, can gobble up amyloid beta protein, which clumps together into toxic aggregates ...

Scientists at UCSF have uncovered how certain immune cells in the brain, called microglia, can effectively digest toxic ...

The Alzheimer's Association® will present 10 scientific awards at the Alzheimer's Association International Conference® 2025 (AAIC®), recognizing researchers for their expertise, noteworthy ...

Alzheimer’s disease could soon be a distant memory. A revolutionary new Alzheimer’s drug named lecanemab could mark a major breakthrough in the decades-long battle against the neurological ...

Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the diagnosis, treatment and care of Alzheimer's and all other ...

Case Western Reserve researchers find that for every 1,000 seniors who had covid, seven will be diagnosed with Alzheimer’s disease within a year, slightly above the five-in-a-thousand diagnosis ...

Massive proteomics database links gene variant APOE 4 to chronic inflammation.

However, unlike most clinical studies, no treatment is tested in ADNI. Instead, participants are followed over a period of years or decades with repeated imaging, including MRI and PET amyloid and tau ...